Lexaria Bioscience (LEXX) Capital Expenditures (QoQ) (2011 - 2025)
Lexaria Bioscience (LEXX) Capital Expenditures (QoQ) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Aug 31, 2025 |
200.00% |
| May 31, 2025 |
-200.00% |
| Feb 28, 2025 |
-100.00% |
| Nov 30, 2024 |
-42.70% |
| Feb 28, 2023 |
-35.38% |
| Nov 30, 2022 |
512,400.00% |
| Aug 31, 2022 |
-99.94% |
| Aug 31, 2019 |
-95.13% |
| May 31, 2019 |
-38.58% |
| Feb 28, 2019 |
159.15% |
| May 31, 2016 |
200.00% |
| Feb 29, 2016 |
-109.99% |
| Jan 31, 2014 |
-8.20% |
| Oct 31, 2013 |
27,132.00% |
| Jul 31, 2013 |
-99.63% |
| Apr 30, 2013 |
-26.93% |
| Jan 31, 2013 |
37.36% |
| Oct 31, 2012 |
-86.61% |
| Jan 31, 2012 |
-93.73% |
| Apr 30, 2011 |
-83.76% |
